1月6日，福瑞医科盘中下跌2.02%，截至13:40，报71.95元/股，成交3.31亿元，换手率1.94%，总市值 190.65亿元。 资金流向方面，主力资金净流出3922.96万元，特大单买入1411.36万元，占比4.27%，卖出2144.14万 元，占比6.48%；大单买入8097.24万元，占比24.48%，卖出1.13亿元，占比34.12%。 责任编辑：小浪快报 福瑞医科所属申万行业为：医药生物-医疗器械-医疗设备。所属概念板块包括：家庭医生概念、融资融 券、基金重仓、中盘、医疗器械等。 截至9月30日，福瑞医科股东户数2.67万，较上期增加3.24%；人均流通股8742股，较上期减少3.09%。 2025年1月-9月，福瑞医科实现营业收入11.01亿元，同比增长12.37%；归母净利润1.12亿元，同比增长 9.69%。 分红方面，福瑞医科A股上市后累计派现2.46亿元。近三年，累计派现5261.06万元。 机构持仓方面，截止2025年9月30日，福瑞医科十大流通股东中，华宝中证医疗ETF（512170）位居第 三大流通股东，持股748.14万股，相比上期减少123.14万股。睿远成长价值混合A ...

健之佳今年以来股价跌10.20%，近5个交易日涨2.33%，近20日跌0.40%，近60日跌8.13%。 分红方面，健之佳A股上市后累计派现7.15亿元。近三年，累计派现4.73亿元。 机构持仓方面，截止2025年9月30日，健之佳十大流通股东中，融通健康产业灵活配置混合A/B （000727）位居第五大流通股东，持股710.00万股，持股数量较上期不变。广发创新升级混合 （002939）退出十大流通股东之列。 资料显示，健之佳医药连锁集团股份有限公司位于云南省昆明市盘龙区联盟街道旗营街10号，成立日期 2004年9月27日，上市日期2020年12月1日，公司主营业务涉及药品、保健食品、个人护理品、家庭健康 用品、便利食品、日用消耗品等健康产品的连锁零售业务,并提供相关专业服务。主营业务收入构成 为：处方、非处方合计(中西成药)72.60%，其中:非处方药39.64%，其中:处方药32.96%，医疗器械 7.44%，其他(补充)5.52%，生活便利品5.05%，保健食品4.84%，中药材3.28%，个人护理品1.18%，体 检服务0.09%。 健之佳所属申万行业为：医药生物-医药商业-线下药店。所属概念板块包 ...

截至9月30日，健之佳股东户数1.51万，较上期减少0.04%；人均流通股10240股，较上期增加0.04%。 2025年1月-9月，健之佳实现营业收入65.49亿元，同比减少2.77%；归母净利润1.01亿元，同比减少 0.22%。 分红方面，健之佳A股上市后累计派现7.15亿元。近三年，累计派现4.73亿元。 12月19日，健之佳盘中下跌2.03%，截至09:38，报19.76元/股，成交1422.32万元，换手率0.46%，总市 值30.54亿元。 资金流向方面，主力资金净流入14.74万元，大单买入154.34万元，占比10.85%，卖出139.60万元，占比 9.81%。 健之佳今年以来股价跌10.24%，近5个交易日涨2.60%，近20日涨0.51%，近60日跌8.18%。 资料显示，健之佳医药连锁集团股份有限公司位于云南省昆明市盘龙区联盟街道旗营街10号，成立日期 2004年9月27日，上市日期2020年12月1日，公司主营业务涉及药品、保健食品、个人护理品、家庭健康 用品、便利食品、日用消耗品等健康产品的连锁零售业务,并提供相关专业服务。主营业务收入构成 为：处方、非处方合计(中西成药)72. ...

来源：新浪证券-红岸工作室 12月11日，中国平安跌0.03%，成交额29.91亿元，换手率0.45%，总市值11322.71亿元。 异动分析 高股息精选+证金持股+互联网保险+独角兽概念 2、公司前十大流通股东中包含中央汇金资产管理有限责任公司或中国证券金融股份有限公司。 3、拥有金融壹账通，向中小银行等金融机构提供电子银行、账户服务、征信、贷款和同业交易等服 务。 4、参股独角兽;旗下拥有陆金所、平安好医生、医保公司、金融一账通等多家独角兽公司,18年5月平安 好医生于中国香港上市;19年3月,旗下陆金所估值394亿美元。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 今日主力净流入-4.11亿，占比0.16%，行业排名5/5，连续3日被主力资金减仓；所属行业主力净流 入-4.85亿，连续3日被主力资金减仓。 区间今日近3日近5日近10日近20日主力净流入-4.44亿-7.34亿6.12亿4.75亿-7.28亿 主力持仓 主力轻度控盘，筹码分布较为分散，主力成交额22.79亿，占总成交额的10.78%。 1、中国平安最近3年的股息率分别为：5.15%，6.03 ...

Core Viewpoint - China Ping An's stock performance shows a slight increase of 0.16% with a trading volume of 28.09 billion yuan and a market capitalization of 1,132.633 billion yuan [1] Dividend Analysis - The dividend yields for China Ping An over the past three years are 5.15%, 6.03%, and 4.84% respectively [2] - The top ten circulating shareholders include Central Huijin Asset Management Co., Ltd. and China Securities Finance Corporation [2] - The company owns Fintech subsidiary OneConnect, providing electronic banking, account services, credit reporting, loans, and interbank transactions to small and medium-sized banks [2] - China Ping An has stakes in several unicorn companies, including Lufax, Ping An Good Doctor, and a health insurance company, with Lufax valued at 39.4 billion USD as of March 2019 [2] Fund Flow Analysis - Today's main capital net inflow is -1.08 million yuan, accounting for 0.05%, with a ranking of 5 out of 5 in the industry, indicating a reduction in main capital positions for two consecutive days [3] - The industry has seen a net inflow of -58.263 million yuan, with a reduction in main capital positions for three consecutive days [3] Technical Analysis - The average trading cost of the stock is 52.96 yuan, with recent accumulation activity noted, although the strength of accumulation is weak [5] - The current stock price is near a resistance level of 63.80 yuan, suggesting caution against potential pullbacks unless the resistance is broken, which could lead to an upward trend [5] Company Overview - China Ping An Insurance (Group) Co., Ltd. is headquartered in Shenzhen, Guangdong, and was established on March 21, 1988, with its listing date on March 1, 2007 [6] - The company offers diversified financial services centered around insurance, including banking, securities, and trust services, with revenue breakdowns of 45.76% from life and health insurance, 34.46% from property insurance, 13.87% from banking, 5.27% from asset management, and 3.85% from financial empowerment [6] - As of September 30, 2025, the company reported a revenue of 832.94 billion yuan, a year-on-year increase of 7.42%, and a net profit attributable to shareholders of 132.856 billion yuan, a year-on-year increase of 11.47% [6] Dividend Distribution - Since its A-share listing, China Ping An has distributed a total of 391.904 billion yuan in dividends, with 134.54 billion yuan distributed over the past three years [7] - As of September 30, 2025, the sixth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 456 million shares, a decrease of 182 million shares from the previous period [7]

思创医惠所属申万行业为：计算机-IT服务Ⅱ-IT服务Ⅲ。所属概念板块包括：DRG概念、家庭医生概 念、多胎概念、新零售、小盘等。 截至9月30日，思创医惠股东户数5.84万，较上期减少11.34%；人均流通股19077股，较上期增加 12.79%。2025年1月-9月，思创医惠实现营业收入6.04亿元，同比增长6.95%；归母净利润-476.22万元， 同比增长98.32%。 分红方面，思创医惠A股上市后累计派现5.32亿元。近三年，累计派现0.00元。 责任编辑：小浪快报 12月1日，思创医惠（维权）盘中下跌2.20%，截至10:18，报4.45元/股，成交2.08亿元，换手率4.13%， 总市值49.75亿元。 资金流向方面，主力资金净流出3019.09万元，特大单买入113.67万元，占比0.55%，卖出1131.77万元， 占比5.45%；大单买入2875.68万元，占比13.85%，卖出4876.67万元，占比23.49%。 思创医惠今年以来股价涨46.38%，近5个交易日跌8.81%，近20日涨23.96%，近60日涨23.27%。 今年以来思创医惠已经5次登上龙虎榜，最近一次登上龙虎榜为11月1 ...

Core Viewpoint - The stock price of Sichuang Medical has increased significantly this year, with a notable rise in recent trading days, indicating strong market interest and potential growth in the healthcare technology sector [2]. Group 1: Stock Performance - Sichuang Medical's stock price has risen by 54.61% year-to-date, with a 4.21% increase in the last five trading days, a 32.02% increase over the last 20 days, and a 27.37% increase over the last 60 days [2]. - The company has appeared on the stock market's "Dragon and Tiger List" five times this year, with the most recent appearance on November 19 [2]. Group 2: Company Overview - Sichuang Medical, established on November 21, 2003, and listed on April 30, 2010, is based in Hangzhou, Zhejiang Province, and focuses on smart hospital solutions, disease research management, and AI services in healthcare [2]. - The company's revenue composition includes 53.84% from real estate sales, 39.28% from business intelligence, and 6.87% from smart healthcare [2]. - Sichuang Medical is classified under the computer-IT services industry and is associated with various concepts such as DRG, family doctor, and new retail [2]. Group 3: Financial Performance - For the period from January to September 2025, Sichuang Medical reported a revenue of 604 million yuan, reflecting a year-on-year growth of 6.95%, while the net profit attributable to shareholders was -4.76 million yuan, showing a significant year-on-year improvement of 98.32% [2]. - As of September 30, the number of shareholders was 58,400, a decrease of 11.34% from the previous period, while the average circulating shares per person increased by 12.79% to 19,077 shares [2]. Group 4: Dividend Information - Since its A-share listing, Sichuang Medical has distributed a total of 532 million yuan in dividends, with no dividends paid in the last three years [3].

Core Viewpoint - China Ping An's stock price has shown a year-to-date increase of 18.91%, with recent fluctuations indicating a slight decline over the past five days and a modest increase over the past 20 days [1] Financial Performance - As of September 30, 2025, China Ping An reported a net profit attributable to shareholders of 132.86 billion yuan, reflecting a year-on-year growth of 11.47% [2] - The company has cumulatively distributed dividends amounting to 391.90 billion yuan since its A-share listing, with 134.54 billion yuan distributed over the past three years [3] Stock Market Activity - On November 25, 2023, China Ping An's stock price reached 59.57 yuan per share, with a trading volume of 2.03 billion yuan and a turnover rate of 0.32% [1] - The net inflow of main funds was 78.15 million yuan, with significant buying and selling activity from large orders [1] Shareholder Information - As of September 30, 2025, the number of shareholders for China Ping An was 696,200, a decrease of 3.43% from the previous period [2] - The average number of circulating shares per shareholder remained unchanged at 15,401 shares [2]

Core Viewpoint - Meinian Health's stock price has shown a positive trend, with a year-to-date increase of 21.04%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Meinian Health reported a revenue of 6.925 billion yuan, a year-on-year decrease of 3.01%, while the net profit attributable to shareholders reached 51.86 million yuan, reflecting a significant year-on-year increase of 110.53% [2]. - The company has cumulatively distributed 634 million yuan in dividends since its A-share listing, with 127 million yuan distributed over the past three years [3]. Stock Market Activity - As of November 17, Meinian Health's stock price was 5.54 yuan per share, with a market capitalization of 21.685 billion yuan. The stock experienced a trading volume of 327 million yuan and a turnover rate of 1.53% [1]. - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent instance on February 19, where it recorded a net buy of -155 million yuan [1]. Shareholder Structure - As of September 30, 2025, Meinian Health had 152,000 shareholders, a decrease of 11.85% from the previous period. The average number of circulating shares per person increased by 13.44% to 25,490 shares [2]. - The top ten circulating shareholders include notable ETFs, with Huabao Zhongzheng Medical ETF holding 88.664 million shares, a decrease of 15.1218 million shares from the previous period [3].

Core Viewpoint - Langma Information's stock price has shown slight fluctuations, with a recent increase of 2.09% and a current price of 14.62 CNY per share, reflecting a market capitalization of 4.941 billion CNY [1] Group 1: Stock Performance - Year-to-date stock price change is +0.10%, with a 5-day increase of 0.69%, a 20-day increase of 6.87%, and a 60-day decrease of 7.35% [1] - As of November 17, the trading volume reached 69.5464 million CNY, with a turnover rate of 1.87% [1] Group 2: Financial Performance - For the period from January to September 2025, Langma Information reported revenue of 224 million CNY, a year-on-year decrease of 24.75%, and a net profit attributable to shareholders of 13.507 million CNY, down 67.04% year-on-year [2] - The company has distributed a total of 112 million CNY in dividends since its A-share listing, with cumulative distributions of 23.6559 million CNY over the past three years [2] Group 3: Shareholder Information - As of November 10, the number of shareholders increased to 36,900, with an average of 6,956 circulating shares per person, a decrease of 0.12% [2] - The fifth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 1.7601 million shares, which is a decrease of 153,700 shares compared to the previous period [2] Group 4: Business Overview - Langma Information, established on September 24, 1998, and listed on February 16, 2012, is primarily engaged in community voice value-added services and internet healthcare information services [1] - The revenue composition includes 65.65% from medical services, 20.48% from medical information services, 9.08% from mobile resale, and smaller contributions from other services [1]